Insider Shareholders with Direct Ownership of Catalyst Pharmaceuticals, Inc. (CPRX)
CPRX Quotes by TradingView
This section provides a comprehensive overview of the insiders with direct ownership of Catalyst Pharmaceuticals, Inc. (CPRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
CATALYST PHARMACEUTICALS, INC. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
Patrick J Mcenany
Director |
2,688,699 | 2,979,693 | 4,481,702 $101 Million | 49 |
Dec 09, 2024
Added 0.08%
|
Steve Miller
Chief Op. & Scientific Officer |
1,010,872 | 718,896 | 949,663 $21.4 Million | 25 |
Feb 14, 2025
Added 1.42%
|
Charles B O'Keeffe
Director |
355,064 | 0 | 732,470 $16.5 Million | 16 |
Feb 14, 2025
Added 0.54%
|
Donald A Denkhaus
Director |
310,079 | 40,000 | 495,079 $11.2 Million | 17 |
Feb 14, 2025
Added 0.8%
|
David S Tierney
Director |
260,079 | 210,000 | 355,620 $8.01 Million | 25 |
Feb 14, 2025
Added 1.11%
|
Richard J Daly
President and CEO |
300,771 | 31,007 | 269,764 $6.08 Million | 19 |
Feb 14, 2025
Reduced 0.58%
|
Philip H Coelho
Director |
148,000 | 158,540 | 204,887 $4.62 Million | 17 |
May 04, 2023
Added 19.62%
|
Brian Elsbernd
Chief Compliance/Legal Officer |
308,400 | 119,836 | 188,564 $4.25 Million | 23 |
Feb 14, 2025
Reduced 1.23%
|
Gary Ingenito
Chief Med. & Reg. Officer |
672,349 | 603,476 | 68,873 $1.55 Million | 34 |
Feb 14, 2025
Reduced 3.41%
|
Alicia Grande
VP, Treasurer and CFO |
633,832 | 974,365 | 55,813 $1.26 Million | 34 |
Dec 27, 2023
Reduced 5.76%
|
Preethi Sundaram
Chief Strategy Officer |
145,188 | 100,183 | 45,005 $1.01 Million | 16 |
Feb 14, 2025
Reduced 11.7%
|
Jeffrey Del Carmen
Chief Commercial Officer |
310,529 | 251,826 | 30,423 $685,430 | 26 |
Feb 14, 2025
Reduced 9.32%
|
Molly Harper
Director |
43,579 | 36,833 | 6,746 $151,987 | 11 |
Feb 14, 2025
Added 37.22%
|
Michael Wayne Kalb
Executive Vice President & CFO |
7,138 | 2,941 | 4,197 $94,558 | 2 |
Jan 02, 2025
Reduced 41.2%
|
Tamar Thompson
Director |
1,413 | 0 | 1,413 $31,834 | 1 |
Dec 09, 2024
Added 50.0%
|
Showing 1 to 15 of 15 entries